Doesn't matter. These are fringe issues. The important points are the bad debt trend, the margin, the loan book growth and not screwing up.
Innovation is then the icing.
Back of the envelope calculation, saving legal cost of 4 million will bump up EBITDA by almost 10 percent. Bad debt is about 30 million. Save a few million there will again drive up the EBITDA. The loan book growth run rate is 4-5 million per month based on July to October data. Annualized rate of about 50 million. The fund facility of 150 million plus retained earning is consistent with the statement that the facility is enough for them to grow loan book till 2020. That means loan book can grow 150 million.
Assuming average net margin of 20 percent (MACC,SACC plus securitised car loan) , EBITDA can easily grow by 80-100 percent in three years.
- Forums
- ASX - By Stock
- CCV
- Ann: CEO Presentation-2017 AGM
Ann: CEO Presentation-2017 AGM, page-24
Featured News
Add CCV (ASX) to my watchlist
(20min delay)
|
|||||
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $138.0M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 23.3¢ | $27.00K | 114.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 278286 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 195090 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 257635 | 0.180 |
1 | 150000 | 0.175 |
5 | 116129 | 0.170 |
6 | 341270 | 0.165 |
4 | 212500 | 0.160 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 40499 | 1 |
0.195 | 128500 | 4 |
0.200 | 66850 | 5 |
0.205 | 7306 | 1 |
0.210 | 2500 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CCV (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online